Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CTSO
CTSO logo

CTSO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cytosorbents Corp (CTSO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
0.410
1 Day change
-5.35%
52 Week Range
1.390
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

CTSO is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading weakly, lacks bullish proprietary signals, has no recent news catalyst, and the technical trend remains bearish. Based on the provided data, the clear action is to avoid buying now.

Technical Analysis

CTSO is in a bearish technical setup. MACD histogram is negative and still below zero, RSI_6 at 42.113 is neutral but weak, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Price at 0.39 is below the pivot at 0.427, which suggests price is not reclaiming momentum. Nearby support is 0.362 and 0.322, while resistance is 0.492 and 0.532. The stock trend data also points lower, with a 70% probability of declines over the next day, week, and month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is not useful as a bullish signal here because there is no meaningful trading volume today. Open interest is heavily skewed to calls versus puts, but with zero option volume and no active flow, it does not confirm positive sentiment. Implied volatility is extremely high at 771.43 with IV percentile 99.6 and IV rank 87.61, which indicates expensive options and heightened speculation rather than stable accumulation.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
1

Positive Catalysts

  • No news in the recent week means there are no immediate event-driven catalysts. Hedge funds and insiders are neutral, and there is no recent congress trading activity. The only mild positive is that pre-market change was +1.74%, but it did not translate into a stronger broader trend.

Neutral/Negative Catalysts

  • Bearish moving averages, negative MACD, weak price structure below pivot, and the stock trend model all point downward. There are no recent news catalysts, no strong hedge fund or insider buying trends, no Congress trading support, and no proprietary buy signal from AI Stock Picker or SwingMax. The lack of financial snapshot data also limits any fundamental support for a buy decision.

Financial Performance

Latest quarter financials were not available due to an error in the provided financial snapshot, so there is no usable revenue or earnings growth readout for the latest quarter season. Because of this, there is no evidence in the data of recent fundamental improvement to support a long-term purchase.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so the Wall Street pros and cons view cannot be fully quantified. Based on the available information, the pro side is minimal: no major negative news and an elevated call open interest base. The con side is stronger: no bullish analyst upgrades, no price target increases, no recent catalysts, and weak technicals. Overall Wall Street evidence in the supplied data leans cautious to negative.

Wall Street analysts forecast CTSO stock price to rise
1 Analyst Rating
Wall Street analysts forecast CTSO stock price to rise
0 Buy
1 Hold
0 Sell
Hold
Current: 0.430
sliders
Low
0.75
Averages
0.75
High
0.75
Current: 0.430
sliders
Low
0.75
Averages
0.75
High
0.75
H.C. Wainwright
Sean Lee
Neutral
downgrade
$1
AI Analysis
2025-11-14
Reason
H.C. Wainwright
Sean Lee
Price Target
$1
AI Analysis
2025-11-14
downgrade
Neutral
Reason
H.C. Wainwright analyst Sean Lee lowered the firm's price target on CytoSorbents to 75c from $1 and keeps a Neutral rating on the shares. The firm reduced estimates to reflect to the "continued drag" on the company's Germany revenues.

People Also Watch